SAN DIEGO, May 8, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of ImmunityBio, Inc. (NASDAQ: IBRX) publicly traded securities between January 19, 2026 and March 24, 2026, both dates inclusive (the "Class Period"), have until...
Hence then, the article about investor deadline immunitybio inc ibrx investors with substantial losses have opportunity to lead securities class action lawsuit was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit )
Also on site :
- 1979 Controversial Kenny Rogers Hit Is One of the 'Greatest Hot Country Songs of All Time,' According to Billboard
- RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias
- 1960s Rock Legend Quietly Bought a Headstone for Blues Icon Bessie Smith Decades After Her Tragic Death